Beyond the blot: Cutting edge tools for genomics, proteomics and metabolomics analyses and previous successes

British Journal of Dermatology

Volumn 166, Issue SUPPL. 2, 2012, Pages 1-8

  Kimball, A B ^a   Grant, R A ^b   Wang, F ^b   Osborne, R ^b   Tiesman, Jay P ^b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b PROCTER AND GAMBLE COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RNA;

BIOLOGY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION PROFILING; GENOME ANALYSIS; GENOMICS; HIGH THROUGHPUT SCREENING; METABOLOME; METABOLOMICS; MICROARRAY ANALYSIS; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEOMICS; REVIEW; RNA SEQUENCE; SEQUENCE ANALYSIS; SKIN FUNCTION; SKIN SURFACE;

CHROMATOGRAPHY; ENZYME-LINKED IMMUNOSORBENT ASSAY; FORECASTING; GENE EXPRESSION; GENOMICS; HUMANS; METABOLOMICS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROTEOMICS; SKIN PHYSIOLOGICAL PROCESSES; SPECTRUM ANALYSIS;

EID: 84862203536     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2012.10859.x     Document Type: Review

References (46)

1. Short RW, Chan JL, Choi JM et al. Effects of moisturization on epidermal homeostasis and differentiation. Clin Exp Dermatol 2007; 32:88-90. (Pubitemid 46006376)
2. Fisher GJ, Kang S, Varani J et al. Mechanisms of photoaging and chronological skin aging. Arch Dermatol 2002; 138:1462-70. (Pubitemid 35315736)
3. Sesto A, Navarro M, Burslem F et al. Analysis of the ultraviolet B response in primary human keratinocytes using oligonucleotide microarrays. Proc Natl Acad Sci USA 2002; 99:2962-70.
4. Schroeder P, Scheike SM, Morita A. Premature skin aging by infrared radiation, tobacco smoke and ozone. In: Skin Aging (Gilchrest BA, Krutmann J, eds). Heidelberg: Springer-Verlag, 2006; 45-53.
5. Bissett DL, Farmer T, McPhail S et al. Genomic expression changes induced by topical N-acetyl glucosamine in skin equivalent cultures in vitro. J Cosmet Dermatol 2007; 6:232-8. (Pubitemid 350214880)
6. Fiehn O. Metabolomics - the link between genotypes and phenotypes. Plant Mol Biol 2002; 48:155-71. (Pubitemid 34128498)
7. Robinson MK, Tiesman JP, Binder RL et al. Immune and inflammatory gene expression profiles of chronological skin aging and photoaging. J Am Acad Dermatol 2008; 58 (Suppl. 2):AB34.
8. Bennett MF, Robinson MK, Baron ED et al. Skin immune systems and inflammation: protector of the skin or promoter of aging. J Investig Dermatol Symp Proc 2008; 13:215-19.
9. Robinson MK, Tiesman JP, Juhlin KD et al. Reduction in gene expression related to inflammation themes by skin barrier improving agent, niacinamide. J Am Acad Dermatol 2009; 60 (Suppl.):AB83.
10. Wang Z, Gerstein M, Snyder M. RNA-Seq: a revolutionary tool for transcriptomics. Nat Rev Genet 2009; 10:57-63.
11. Witzmann FA, Grant RA. Pharmacoproteomics in drug development. Pharmacogenomics J 2003; 3:69-76. (Pubitemid 36675707)
12. Robinson MK. Noninvasive clinical assessment of skin irritation/ inflammation. In: Handbook of Cosmetic Science and Technology (Barel AO, Paye M, Maibach HI, eds), 3rd edn. New York: Informa Healthcare, 2009; 481-8.
13. Kerr K, Darcy T, Henry J et al. Epidermal changes associated with symptomatic resolution of dandruff: biomarkers of scalp health. Int J Dermatol 2011; 50:102-13.
14. Picotti P, Bodenmiller B, Mueller LN et al. Full dynamic range proteome analysis of S. cerevisiae by targeted proteomics. Cell 2009; 138:795-806.
15. Shockcor JP, Holmes E. Metabonomic applications in toxicity screening and disease diagnosis. Curr Top Med Chem 2002; 2:35-51.
16. Nicholson JK, Wilson ID. Understanding 'global' systems biology: metabonomics and the continuum of metabolism. Nat Rev Drug Discov 2003; 2:668-76. (Pubitemid 37361770)
17. Nicholson JK, Lindon JC, Holmes E. 'Metabonomics': understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. Xenobiotica 1999; 29:1181-9.
18. Kuhara T. Gas chromatographic-mass spectrometric urinary metabolome analysis to study mutations of inborn errors of metabolism. Mass Spectrom Rev 2005; 24:814-27. (Pubitemid 41641699)
19. Lisec J, Schauer N, Kopka J et al. Gas chromatography mass spectrometry-based metabolite profiling in plants. Nat Protoc 2006; 1:387-96.
20. Wagner S, Scholz K, Donegan M et al. Metabonomics and biomarker discovery: LC-MS metabolic profiling and constant neutral loss scanning combined with multivariate data analysis for mercapturic acid analysis. Anal Chem 2006; 78:1296-305. (Pubitemid 43271864)
21. Williams RE, Major H, Lock EA et al. D-Serine-induced nephrotoxicity: a HPLC-TOF/MS-based metabonomics approach. Toxicology 2005; 207:179-90. (Pubitemid 39642834)
22. Simons K, Vaz WLC. Model systems, lipid rafts, and cell membranes. Annu Rev Biophys Biomol Struct 2004; 33:269-95. (Pubitemid 38829961)
23. Bissett DL, Oblong JE, Saud A et al. Topical niacinamide provides skin aging appearance benefits while enhancing barrier function. J lin Dermatol 2003; 32:S9-18.
24. Soma Y, Kashima M, Imaizumi A et al. Moisturizing effects of topical nicotinamide on atopic dry skin. Int J Dermatol 2005; 44:197-202. (Pubitemid 40425662)
25. Draelos ZD. Niacinamide-containing facial moisturizer improves skin barrier and benefits subjects with rosacea. Cutis 2005; 76:135-41.
26. Hakozaki T, Minwalla L, Zhuang J et al. The effect of niacinamide on reducing cutaneous pigmentation and suppression of melanosome transfer. Br J Dermatol 2002; 147:22-33.
27. Matts PJ, Oblong JE, Bissett DL. A review of the range of effects of niacinamide in human skin. Int Fed Soc Cosmet Chem Mag 2002; 5:285-9.
28. Bissett DL. Topical niacinamide and barrier enhancement. Cutis 2002; 70S:8-12.
29. Osborne R, Matsubara A, Biedermann K et al. Improvement in facial surface sebum and pore appearance with niacinamide. Poster presented at the 61st Annual Meeting of the American Academy of Dermatology, San Francisco, CA, U.S.A., 2003.
30. Osborne R, Rose-Mansfield R, Matsubara A et al. Reduction in skin surface sebum with cosmetic ingredients. Poster presented at the 22nd World Congress of Dermatology, Seoul, Korea, 2011.
31. McGrath JA, Robinson MK, Binder RL. Skin differences based on age and chronicity of ultraviolet exposure: results from a gene expression profiling study. Br J Dermatol 2012; 166 (Suppl. 2):9-15.
32. Jarrold B, Mullins L, Binder R et al. Expression profiles of stratum corneum lipid metabolism pathways. J Am Acad Dermatol 2009; 60 (Suppl.):AB28.
33. Jarrold B, Tiesman J, Robinson M et al. Hexamidine, a protease inhibitor, promotes stratum corneum lipid biomarkers in vitro. J Am Acad Dermatol 2010; 62 (Suppl.):AB2.
34. Green C, Orchard G, Cerio R et al. A clinicopathological study of the effects of topical retinyl propionate cream in skin photoageing. Clin Exp Dermatol 1998; 23:162-7. (Pubitemid 28539502)
35. Semenzato A, Bovenga L, Faiferri L et al. Stability of vitamin A propionate in cosmetic formulations. SOFW J 1997; 123:151-4.
36. Katayama K, Armendariz-Borunda J, Raghow R et al. A pentapeptide from type 1 procollagen promotes extracellular matrix production. J Biol Chem 1993; 268:9941-4. (Pubitemid 23150163)
37. Lintner K. Promoting ECM production without compromising barrier. Ann Dermatol Venereol 2002; 129:1S105.
38. Lintner K. Promoting production in the extracellular matrix without compromising barrier. Cutis 2002; 70S:13-16.
39. Mas-Chamberlin C, Lintner K, Basset L et al. Relevance of antiwrinkle treatment of a peptide: 4 months clinical double blind study vs. excipient. Ann Dermatol Venereol 2002; 129:1S456.
40. Lintner K, Robinson L, Bissett D. Palmitoyl-pentapeptide: retinol-like efficacy with less irritation. Poster presented at the 61st Annual Meeting of the American Academy of Dermatology, San Francisco, CA, U.S.A., 2003.
41. Bissett D, Robinson LR, Berge CA et al. Topical palmitoyl pentapeptide: effective agent to reduce the appearance of facial aging. Poster presented at the 61st Annual Meeting of the American Academy of Dermatology, San Francisco, CA, U.S.A., 2003.
42. Robinson LR, Fitzgerald NC, Doughty DG et al. Topical palmitoyl pentapeptide provides improvement in photoaged human facial skin. Int J Cosmet Sci 2005; 27:155-60. (Pubitemid 40705298)
43. Osborne R, Robinson L, Berge C et al. Use of a facial moisturizer containing pal-KTTKS peptide improves the appearance of aging skin. Poster presented at the 64th Annual Meeting of the American Academy of Dermatology, San Francisco, CA, U.S.A., 2006.
44. Mondon P, Doridot E, Peschard O et al. Reduced appearance of facial wrinkles with Pal-KTTKS peptide containing moisturizer. Poster presented at the 22nd World Congress of Dermatology, Seoul, Korea, 2011.
45. Mullins L, Jarrold B, Lintner K, Osborne R. In vitro skin biomarker responses to a new antiaging peptide, Pal-KT. J Am Acad Dermatol 2009; 60 (Suppl.):AB82.
46. Osborne R, Hakozaki T, Laughlin T, Finlay DR. Application of genomics to breakthroughs in the cosmetic treatment of skin ageing and discoloration. Br J Dermatol 2012; 166 (Suppl. 2):-16-19.